In short: Classic vaccines have picked most of the low-hanging fruit: stable-antigen pathogens tamed by robust neutralizing antibodies, leaving the real fun to TB, HIV and other shape-shifters that demand sophisticated...
Pakistan: Nationwide HPV Rollout Pakistan launched a nationwide human papillomavirus (HPV) vaccination campaign targeting girls aged 9–14. With support from Gavi, UNICEF, and WHO, the program aims to reach 13 million...
This population-based, exposure-matched cohort study assessed the incidence of medically attended adverse events following COVID-19 vaccination and SARS-CoV-2 infection in over one million pregnant and non-pregnant...
On May 21, 2025, Moderna, announced a significant update regarding its flu/COVID combination vaccine candidate, mRNA-1083. In consultation with the U.S. Food and Drug Administration (FDA), Moderna has voluntarily...
As the northern hemisphere prepares for the 2025/26 respiratory virus season, both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), as well as the World Health Organization (WHO)...
Cornell researchers have developed a new vaccine platform that could provide more robust, longer-lasting protection from both COVID-19 and influenza, and broader immunity to different flu strains. In a study published...
As the COVID-19 pandemic continues to transition toward endemicity, the global community faces the complex challenge of adapting booster vaccination strategies to meet diverse needs. While some countries, like the...
Australia’s pioneering mRNA COVID-19 vaccine has shown promising results in overcoming immune imprinting, a challenge that limits immune responses to new virus variants. The findings, published in Molecular Therapy...
A one-size-fits-all approach for scheduling COVID-19 booster shots may not be the most effective, according to a new study by researchers at the Yale School of Public Health (YSPH) and University of North Carolina at...
Researchers at Columbia University Vagelos College of Physicians and Surgeons have uncovered how COVID-19 mRNA vaccines bolster the immune system by generating memory T and B cells, critical for long-term immunity...